1
0
0
(1 - 21 von 25
)
Author Search ResultsUniversidad Veracruzana
ebusca.uv.mx
... William Lumry M.D., Debora Williams-Herman M.D., Jonathan Edelman M.D., Henrike Feuersenger Ph.D., Thomas Machnig M.D., Mikhail Rojavin Ph.D.
Treatment response after repeated administration of C1 esterase ...www.ingentaconnect.com › ocean › aap › art00009
www.ingentaconnect.com
... Jonathan A. Bernstein, M.D.8; Mikhail A. Rojavin, Ph.D.9; Thomas Machnig, M.D.10; Heinz-Otto Keinecke, M.Sc.11; Richard L. Wasserman, M.D., Ph.D.12.
Articles - Allergy, Asthma & Clinical ImmunologyAllergy, Asthma & Clinical Immunology
aacijournal.biomedcentral.com
... Jonathan Bernstein, Michael Manning, Donald Levy, Marc A. Riedl, Henrike Feuersenger, Subhransu Prusty, Ingo Pragst, Thomas Machnig and Timothy Craig.
Official Journal of the Canadian Society of Allergy and OALibwww.oalib.com › journal
www.oalib.com
Girishanthy Krishnarajah,Huamin Henry Li,John-Philip Lawo,Jonathan A. Bernstein,Michael E. Manning,Thomas Machnig,Timothy J. Craig ...
Effect of time to treatment on response to C1 esterase inhibitor ...Annals of Allergy, Asthma & Immunology
www.annallergy.org
Rojavin, PhD, Thomas Machnig, MD, Heinz-Otto Keinecke, MS, Jonathan A. Bernstein, MD. Annals of Allergy, Asthma & Immunology. Volume 111 Issue 3 Pages Rojavin, PhD, Thomas Machnig, MD, Heinz-Otto Keinecke, MS, Jonathan A. Bernstein, MD. Annals of Allergy, Asthma & Immunology. Volume 111 Issue 3 Pages
Effect of time to treatment on response to C1 esterase ...Penn State
pure.psu.edu
von TJ Craig · · Zitiert von: 65 — Rojavin, Thomas Machnig, Heinz Otto Keinecke, Jonathan A. Bernstein. Department of Medicine · Division of Pulmonary, Allergy and Critical Care Medicine ... von TJ Craig · · Zitiert von: 65 — Rojavin, Thomas Machnig, Heinz Otto Keinecke, Jonathan A. Bernstein. Department of Medicine · Division of Pulmonary, Allergy and Critical Care Medicine ...
Penn State University
pure.psu.edu
Rojavin, Thomas Machnig, Heinz Otto Keinecke, Jonathan A. Bernstein. Department of Medicine · Division of Pulmonary, Allergy and Critical Care Medicine ...
Dr. Timothy Craig, DO – Hershey, PA | Allergy & Immunology
www.doximity.com
Jonathan A. Bernstein, Huamin Henry Li, Timothy J. Craig, Hilary J. Longhurst, Henriette Farkas, Michael E. Manning, Thomas Machnig, John-Philip Lawo, and others, Journal of Allergy and Clinical Immunology, Atlanta, GA, Nurse Practitioners and PAs, already on Doximity. Find your profile and take control of your online presence: * *
Efficacy and Safety of an Intravenous C1-Inhibitor ...Icahn School of Medicine at Mount Sinai
scholars.mssm.edu
... Jonathan Edelman, Henrike Feuersenger, Thomas Machnig, Mikhail Rojavin, Berinert Registry investigators The Berinert Registry investigators.
Effect of time to treatment on response to C1 esterase inhibitor...
www.infona.pl
... inhibitor concentrate for hereditary angioedema attacks. Timothy J. Craig, Mikhail A. Rojavin, Thomas Machnig, Heinz-Otto Keinecke, Jonathan A. Bernstein.
Efficacy of Different Medical Therapies for the Treatment of Acute...
pubmed.ncbi.nlm.nih.gov
Authors. Konrad Bork , Jonathan A Bernstein , Thomas Machnig , Timothy J Craig. Affiliations. 1 Department of Dermatology, University of Mainz, Mainz, ...
Efficacy of Different Medical Therapies for the Treatment of Acute...
cyberleninka.org
Abstract of research paper on Clinical medicine, author of scientific article — Konrad Bork, Jonathan A. Bernstein, Thomas Machnig, Timothy J. Craig. Abstract ...
Efficacy of C1-Inhibitor Concentrate (Berinert ® ) for the Treatment...
schlr.cnki.net
Konrad Bork,Petra Staubach,Jonathan A. Bernstein,Henrike Feuersenger, Thomas Machnig,Timothy J. Craig. The Journal of Allergy and Clinical Immunology.
Subcutaneous C1 inhibitor for prevention of attacks ...DataCite
commons.datacite.org
James Baker. William Lumry. Jonathan Bernstein. Michael Manning. Donald Levy. Marc Riedl. Henrike Feuersenger. Subhransu Prusty. Ingo Pragst. Thomas Machnig.
Safety of C1-Esterase Inhibitor in Acute and Prophylactic Therapy of...
schlr.cnki.net
Paula Busse,Anette Bygum,Jonathan Edelman,William Lumry,Thomas Machnig, Inmaculada Martinez-Saguer,Mikhail Rojavin. The Journal of Allergy and ...
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1...
en.x-mol.com
... G Gower,Debra Bensen-Kennedy,Jonathan Edelman,Henrike Feuersenger,John-Philip Lawo,Thomas Machnig,Dipti Pawaskar,Ingo Pragst,Bruce L Zuraw,
The effect of weight on the efficacy and safety of C1 esterase ...Elsevier
pennstate.pure.elsevier.com
Jonathan A. Bernstein, Thomas Machnig, Heinz Otto Keinecke, Glenn J. Whelan, Timothy Craig · Department of Medicine · Department of Pediatrics · Division of ...
Subcutaneous C1 inhibitor for prevention of attacks of hereditary...
pennstate.pure.elsevier.com
... Jonathan Bernstein, Michael Manning, Donald Levy, Marc A. Riedl, Henrike Feuersenger, Subhransu Prusty, Ingo Pragst, Thomas Machnig, ...
Safety of C1-esterase inhibitor in acute and PubMedpubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
Authors. Paula Busse , Anette Bygum , Jonathan Edelman , William Lumry , Thomas Machnig , Inmaculada Martinez-Saguer , Mikhail Rojavin ...
Presentation: C1-Esterase Inhibitor Concentrate for Acute Laryngeal...
aaaai.confex.com
· Konrad Bork, Jonathan A. Bernstein, MD FAAAAI, Thomas Machnig, Timothy J. Craig. Rationale: For acute treatment of hereditary angioedema ...
Alle Infos zum Namen "Thomas MacHnig"
sortiert nach Relevanz / Datum